General Western Blot Reagents
Abcam 410/450 nm E x tracellular Vesicle Membrane Staining Kit, 500 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using 410/450 nm Extracellular Vesicle Membrane Staining Kit ab314685. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fi x able Viability Dye (750/777), 200 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using Fixable Viability Dye (750/777) ab314682. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fi x able Viability Dye (750/777), 50 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using Fixable Viability Dye (750/777) ab314682. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 410/450 nm E x tracellular Vesicle Membrane Staining Kit, 100 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using 410/450 nm Extracellular Vesicle Membrane Staining Kit ab314685. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ENE2 (Extraction Buffer).
ENE2 (Extraction Buffer).
The product is subject to the following: Abcam Restricted Use Statement
Genhunter Corporation PerfectWestern, Medium Rainbow Set of 6 colors
Set, Rainbow; Genhunter; PerfectWestern; Container for whole mini-proteingels; Dimensions: 9.1 x 6.6 x 2.9cm; Size: medium
Abcam Caged MK 801, NMDA receptor open-channel blocker, 10MG
MW 460.49 g/mol, Purity >99%. Caged, potent, selective, non-competitive, irreversible NMDA receptor open-channel blocker. UV-active MK 801 (ab144485, ab120027, ab120028) analog. Shows anticonvulsant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Aeroplysinin (Aeroplysinin-1), antiangiogenic agent, 1MG
MW 338.98 Da, Purity >95%. Potent antiangiogenic agent. Inhibits COX-2 expression. Selectivity for endothelial cells. Able to induce apoptosis via capsase activation, chromatin condensation and nuclear fragmentation. Antibiotic and cytotoxic effects (IC₅₀ = 3 μm) and displays a wide-spectrum antitumor activity. Active in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bleomycin sulfate, anticancer and antibiotic agent, 10MG
MW 1512.6 Da, Purity >98%. Radiomimetic anticancer and antibiotic agent. Induces oxidative stress and DNA damage via single strand breaks, double strand breaks and apurinic/apyrimidinic modifications. Shows anticancer effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Auranofin, inhibits both leukocyte activation pathways, 50MG
MW 678.5 Da, Purity >98%. Organic gold compound. Anti-inflammatory and antiproliferative agent. Glutathione S-transferase P1-1 inhibitor (IC50 = 33 μM). Shows antiproliferative effects through STAT3 inhibition. Shows anti-inflammatory effects *in vivo*. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Minocycline hydrochloride, Antibiotic, 50MG
MW 493.94 g/mol, Purity >98%. Antibiotic. Demonstrates anti-inflammatory, antiapoptotic, antioxidant and neuroprotective effects. Blood-brain barrier permeable. Matrix metalloproteinase (MMP) inhibitor (IC₅₀ = 290 μM at stromelysin (MMP-3).
The product is subject to the following: Abcam Restricted Use Statement
Abcam C6 Ceramide, biologically active ceramide analog, 5MG
MW 397.6 Da, Purity >98%. Non-physiological and biologically active ceramide analog. Various pharmacological activities including activation of protein phosphatase 2A and MAPK, suppression of insulin-induced tyrosine phosphorylation and induction of cell cycle arrest at the G0/G1 transition. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-161,982, EP4 receptor antagonist, 10MG
MW 654.72 g/mol, Purity >98%. Potent EP₄ receptor antagonist, selective over all other prostanoid receptor family members (Ki values for human receptors are 0.024 (EP₄), 0.71 (TP), 1.90 (EP₃), 5.10 (DP), 5.63 (FP), 6.74 (IP), 19 (EP₁) and 23 μM ( EP₂)). Shows a variety of biological actions including suppression of PGE₂ stimulated bone formation, blocking of cell proliferation and also reverses anti-inflammatory action of PGE₂.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Bisoprolol hemifumarate, beta1 antagonist, 50MG
MW 383.48 g/mol, Purity >99%. Selective β₁ antagonist (Ki = 22.4 nM). Antihypertensive agent.
The product is subject to the following: Abcam Restricted Use Statement